PharmacovigilanceOfficial
EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation
🇪🇺 EMA · Fri 20 Nov 2026
The EU's single assessment of periodic safety reports for ibuprofen, ibuprofen lysine and ibuprofen/caffeine has ended in a regulatory outcome of variation, with documents now online.
The European Medicines Agency has published the outcome of periodic safety update report single assessment PSUSA/00010649/202602, covering ibuprofen, ibuprofen lysine and the fixed combination of ibuprofen and caffeine. The documents went online on 20 November 2026.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (EMA). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk
🇺🇸 FDA MedWatch · Fri 20 Nov 2026
EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation
🇪🇺 EMA · Fri 20 Nov 2026
CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice
🇺🇸 CMS · Fri 20 Nov 2026
CMS issues proposed rule on 2028 Medicare Advantage and Part D changes
🇺🇸 CMS · Fri 20 Nov 2026
FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study
🇺🇸 FDA CBER · Fri 20 Nov 2026
Breckenridge recalls one lot of propranolol ER 60 mg capsules over possible metal contamination
🇺🇸 FDA MedWatch · Fri 20 Nov 2026